In an adult with post‑concussion syndrome and depressive symptoms, which antidepressants are most appropriate?

Antidepressant Selection for Post-Concussion Syndrome with Depression

For adults with post-concussion syndrome and depressive symptoms, selective serotonin reuptake inhibitors (SSRIs) are the recommended first-line pharmacotherapy, with sertraline being the preferred agent based on stroke rehabilitation guidelines and general depression evidence. 1, 2

Primary Recommendation: SSRIs or SNRIs

The most recent stroke rehabilitation guidelines (2025) from the U.S. Department of Veterans Affairs and Department of Defense provide the strongest applicable evidence, suggesting SSRIs or serotonin-norepinephrine reuptake inhibitors (SNRIs) for depression symptoms following neurological injury. 1 While these guidelines address post-stroke depression rather than post-concussion syndrome specifically, the neuropsychiatric sequelae are comparable, and this represents the highest-quality guideline evidence available for depression after brain injury.

Specific Agent Selection

Sertraline (50-200 mg/day) is the preferred first-line SSRI because: 2

• Excellent tolerability profile with lower sexual dysfunction rates compared to paroxetine 2
• Particularly recommended for older adults 2
• Strong evidence base in general depression treatment 3

Escitalopram (10-20 mg/day) is an appropriate alternative with: 2

• Modestly higher efficacy than citalopram (odds ratio ≈ 1.14) 2
• Comparable tolerability and lower discontinuation rates 2
• Maximum dose of 20 mg/day in hepatic impairment 2

Alternative Agents When SSRIs Are Inappropriate

Bupropion (100-400 mg/day) should be selected when: 2

• Sexual dysfunction is a primary concern (markedly fewer sexual adverse effects than SSRIs) 2
• Patients require cognitive enhancement, as tricyclic antidepressants and gabapentin have shown short-term cognitive symptom improvement in post-concussion patients 4

Mirtazapine (15-45 mg/day) is appropriate when: 2

• Rapid symptom relief is needed (faster onset within 4 weeks compared to SSRIs) 2
• Sleep disturbance is prominent, given its sedating properties 5

Agents to Avoid

Do not prescribe paroxetine as first-line therapy because: 2

• Higher anticholinergic activity than other SSRIs 2
• Greater sexual dysfunction burden 2
• Should be avoided in older adults 2

Do not prescribe fluoxetine as first-line therapy because: 2

• Increased risk of agitation and overstimulation 2
• Not recommended for older adults 2
• Less favorable profile in post-concussion populations 6

Critical Clinical Considerations

Dosing in Special Populations

Older adults (≥65 years): 2

• Initiate at 50% of standard adult dose to reduce adverse drug reactions 2
• Preferred agents: escitalopram, sertraline, mirtazapine, or bupropion 2

Hepatic impairment: 2

• Limit escitalopram to maximum 20 mg/day 2
• Dose reductions required for bupropion, venlafaxine, and duloxetine 2

Renal impairment: 2

• Dose adjustments necessary for bupropion, venlafaxine, and duloxetine 2

Monitoring Protocol

Begin clinical monitoring within 1-2 weeks of treatment initiation for: 2

• Suicidal ideation (critical in post-concussion populations) 2
• Therapeutic response 2
• Adverse effects 2

Approximately 38% of patients fail to achieve clinical response with the first antidepressant trial, necessitating close follow-up and potential medication adjustment. 2

Treatment Duration

After remission of depressive symptoms: 2

• Continue treatment for 4-12 months for first episode 2
• Extend duration for recurrent depression 2
• Gradually taper dosage while providing cognitive behavioral therapy to decrease relapse risk 7

Adjunctive Psychotherapy

Cognitive behavioral therapy (CBT) should be offered concurrently with pharmacotherapy when possible, as the combination is preferred for severe depression. 1, 3, 7 Psychotherapy alone showed similar response rates to antidepressants in general depression (RR 0.98), with lower discontinuation due to adverse events (0.8% vs 6.2%). 3

Mindfulness-based therapies are also suggested as adjunctive treatment for depression following neurological injury. 1

Important Caveats

Depression and antidepressant use are both independently associated with greater post-concussion symptom burden. 8 Young athletes with depression/anxiety experience significantly greater symptom burden compared to healthy controls regardless of antidepressant use, suggesting that medication alone may not fully address symptom severity. 8

Antidepressants should still be prescribed despite mixed evidence in traumatic brain injury populations, because patients may: 9

• Benefit from robust placebo effects 9
• Benefit from alternative or adjunctive medication if first agent fails 9
• Make improvements not captured by traditional depression measures 9

Mild traumatic brain injury is not a contraindication for antidepressant therapy. 9 Patients with mild TBI more closely resemble those in primary major depressive disorder trials than severe TBI patients, making them especially appropriate for standard antidepressant treatment. 9